HopeStage
Back to all studies
CompletedNCT01909011

A Single Blind Study of Cranial Electrical Stimulation in Bipolarity type II

Device studyAges 18–85United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 85 years.

Listed locations
New YorkSee all locations and recruitment
Study clarity

Study information

Study start dateJanuary 2013
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
Beth Israel Medical Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 85 Years
Official registry ID
NCT01909011
Official title
Show the full official title

A Single Blind, Randomized, Sham Controlled Study of Cranial Electrical Stimulation in Bipolar II Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Beth Israel Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 85 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me